Researchers have developed a new laser-based technique that targets pancreatic ductal adenocarcinoma (PDAC) while leaving healthy tissue intact. PDAC is the most common type of pancreatic cancer and the third leading cause of death related to cancer.
A new way of diagnosing heavy bleeding after birth (postpartum hemorrhage or PPH) is more effective at identifying women in need of treatment than the current diagnostic method, suggests a meta-analysis published in The Lancet.
Cervical epithelial cells are far from passive bystanders in the body’s immune system. New research shows they actually play an active and highly coordinated role in detecting and fighting infections. That’s the conclusion of an international research team led by Associate Professor Cindrilla Chumduri from Aarhus University, published in the journal Science Advances.
Three scientists won the Nobel Prize in medicine Monday for discoveries about how the immune system knows to attack germs and not our own bodies.
Neurons in the brain communicate with each other through synapses—connection points that allow the passage of electrical and chemical signals. In non-neuronal cells, direct cell-to-cell connections have been found to occur with the assistance of nanotube structures
Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease progression and survival in patients with fibrotic interstitial lung disease.
NEWPORT BEACH, Calif., Oct. 3, 2025 /PRNewswire/ — Gnosis for Her, a mobile breast health initiative redefining comfort and access in women’s breast imaging, made its national debut this past weekend at Susan G. Komen’s More Than Pink Walk at Fashion Island. More than 6,000 breast cancer survivors, loved ones, advocates, and supporters had the opportunity to see the Mobile Care Unit up close, tour inside, and speak with the expert team behind the service.
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases (IBD), but also successfully used a new type of AI to predict exactly how the drug works. To their knowledge, this is a global first for the AI.
Trying to document how single brain cells participate in networks that govern behavior is a daunting task. Brain probes called Neuropixels, which feature high-density silicon arrays, have enabled scientists to collect electrophysiological data of this nature from a variety of animals
MIT CSAIL and McMaster researchers used a generative AI model to reveal how a narrow-spectrum antibiotic attacks disease-causing bacteria, speeding up a process that normally takes years.